ARTV · Artiva Biotherapeutics Inc. Common Stock
View on chartInsiders & Stakes
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Open Market | 17,329,570 Shares held | 7/31/2026 | View profile |
| venBio Global Strategic Fund III, L.P. | ▲ Buy | Open Market | 1,936,637 Shares held | 7/22/2024 | View profile |
| GC Corp. | ▲ Buy | Open Market | 1,607,734 Shares held | 5/11/2026 | View profile |
| Aslan Fred Chief Executive Officer | ▼ Sell | Open Market | 1,519,606 Shares held | 10/6/2026 | View profile |
| Huh Yong-Jun | ▲ Buy | Open Market | 1,260,512 Shares held | 7/22/2024 | View profile |
| 5AM Partners VI, LLC 10% Owner | ▲ Buy | Open Market | 1,182,054 Shares held | 7/22/2024 | View profile |
| Bush Jennifer COO, CLO, Compliance Officer | ▼ Sell | Open Market | 366,159 Shares held | 10/5/2026 | View profile |
| Horan Christopher Chief Tech Operations Officer | ▼ Sell | Open Market | 312,744 Shares held | 10/5/2026 | View profile |
| Huston Thad Allen Chief Financial Officer | ▲ Buy | Grant | 220,000 Shares held | 3/10/2026 | View profile |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | ▼ Sell | Other | 194,108 Shares held | 7/22/2024 | View profile |
| Banerjee Subhashis Chief Medical Officer | ▼ Sell | Open Market | 169,848 Shares held | 10/5/2026 | View profile |
| Raymon Heather SVP, Research and Development | ▼ Sell | Open Market | 148,228 Shares held | 5/19/2026 | View profile |
| Miralles Gines Diego President & Head of R&D | ▲ Buy | Grant | 122,500 Shares held | 9/9/2026 | View profile |
| Neha Krishnamohan Chief Financial Officer | ▼ Sell | Tax Withholding | 99,356 Shares held | 11/15/2025 | View profile |
| Graef Thorsten Chief Medical Officer | ▲ Buy | Grant | 80,000 Shares held | 2/26/2025 | View profile |
Transaction History
| Aslan Fred | ▼ Sell | Open Market | 23,463 | $169K | 10/6/2026 |
| Horan Christopher | ▼ Sell | Open Market | 10,340 | $71K | 10/5/2026 |
| Bush Jennifer | ▼ Sell | Open Market | 8,370 | $57K | 10/5/2026 |
| Banerjee Subhashis | ▼ Sell | Open Market | 1,099 | $8K | 10/5/2026 |
| Aslan Fred | ▼ Sell | Open Market | 61,696 | $422K | 10/5/2026 |
| Aslan Fred | ▲ Buy | Grant | 110,000 | $0 | 9/15/2026 |
| Aslan Fred | ▲ Buy | Grant | 45,000 | $0 | 9/10/2026 |
| Bush Jennifer | ▲ Buy | Grant | 45,000 | $0 | 9/9/2026 |
| Miralles Gines Diego | ▲ Buy | Grant | 45,000 | $0 | 9/9/2026 |
| Horan Christopher | ▲ Buy | Grant | 40,000 | $0 | 9/9/2026 |
| Banerjee Subhashis | ▲ Buy | Grant | 30,000 | $0 | 9/9/2026 |
| Aslan Fred | ▼ Sell | Open Market | 23,429 | $256K | 9/8/2026 |
| Horan Christopher | ▼ Sell | Open Market | 10,366 | $116K | 9/3/2026 |
| Bush Jennifer | ▼ Sell | Open Market | 8,391 | $94K | 9/3/2026 |
| Banerjee Subhashis | ▼ Sell | Open Market | 1,100 | $12K | 9/3/2026 |
| Aslan Fred | ▼ Sell | Open Market | 61,888 | $690K | 9/3/2026 |
| Banerjee Subhashis | ▲ Buy | Option Exercise | 5,306 | $10K | 8/27/2026 |
| Banerjee Subhashis | ▼ Sell | Open Market | 8,222 | $99K | 8/27/2026 |
| Banerjee Subhashis | ▲ Buy | Option Exercise | 429 | $824 | 8/18/2026 |
| Banerjee Subhashis | ▼ Sell | Open Market | 429 | $5K | 8/18/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 24,944 | $248K | 7/31/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 20,824 | $208K | 7/29/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 41,319 | $413K | 7/24/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 59,880 | $596K | 7/23/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 84,124 | $835K | 7/22/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 120,582 | $1.2M | 7/21/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 7,882 | $71K | 7/17/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 152,472 | $1.4M | 7/16/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 6,552 | $59K | 7/13/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 15,102 | $135K | 7/10/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 1,876 | $17K | 6/26/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 31,000 | $275K | 6/25/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 124,893 | $1.1M | 6/16/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 15,414 | $139K | 6/15/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 391,019 | $3.4M | 6/12/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 548,580 | $4.3M | 6/11/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 103 | $721 | 6/10/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 479,039 | $3.3M | 6/9/2026 |
| Aslan Fred | ▼ Sell | Open Market | 27,116 | $244K | 5/19/2026 |
| Banerjee Subhashis | ▼ Sell | Open Market | 7,037 | $63K | 5/19/2026 |
| Raymon Heather | ▼ Sell | Open Market | 3,095 | $28K | 5/19/2026 |
| Horan Christopher | ▼ Sell | Open Market | 7,002 | $63K | 5/19/2026 |
| Bush Jennifer | ▼ Sell | Open Market | 8,790 | $79K | 5/19/2026 |
| Miralles Gines Diego | ▲ Buy | Grant | 77,500 | $0 | 5/18/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 6,510,416 | $75.0M | 5/11/2026 |
| GC Corp. | ▲ Buy | Open Market | 1,085,069 | $12.5M | 5/11/2026 |
| GC Corp. | ▲ Buy | Open Market | 347,222 | $4.0M | 5/11/2026 |
| Huston Thad Allen | ▲ Buy | Grant | 220,000 | $0 | 3/10/2026 |
| Raymon Heather | ▼ Sell | Tax Withholding | 1,521 | $6K | 2/15/2026 |
| Horan Christopher | ▲ Buy | Grant | 117,300 | $0 | 2/15/2026 |
| Bush Jennifer | ▲ Buy | Grant | 117,300 | $0 | 2/15/2026 |
| Bush Jennifer | ▼ Sell | Tax Withholding | 3,515 | $14K | 2/15/2026 |
| Banerjee Subhashis | ▲ Buy | Grant | 102,000 | $0 | 2/15/2026 |
| Aslan Fred | ▼ Sell | Tax Withholding | 14,600 | $58K | 2/15/2026 |
| Raymon Heather | ▲ Buy | Grant | 46,000 | $0 | 2/15/2026 |
| Aslan Fred | ▲ Buy | Grant | 366,850 | $0 | 2/15/2026 |
| Horan Christopher | ▼ Sell | Tax Withholding | 2,187 | $9K | 2/15/2026 |
| Aslan Fred | ▼ Sell | Open Market | 3,187 | $19K | 12/15/2025 |
| Raymon Heather | ▲ Buy | Grant | 67,253 | $0 | 12/12/2025 |
| Horan Christopher | ▲ Buy | Grant | 107,156 | $0 | 12/12/2025 |
| Bush Jennifer | ▲ Buy | Grant | 84,877 | $0 | 12/12/2025 |
| Aslan Fred | ▲ Buy | Grant | 869,136 | $0 | 12/12/2025 |
| Aslan Fred | ▼ Sell | Open Market | 6,375 | $22K | 11/17/2025 |
| Raymon Heather | ▼ Sell | Tax Withholding | 1,375 | $4K | 11/15/2025 |
| Horan Christopher | ▼ Sell | Tax Withholding | 1,899 | $6K | 11/15/2025 |
| Bush Jennifer | ▼ Sell | Tax Withholding | 3,055 | $10K | 11/15/2025 |
| Neha Krishnamohan | ▼ Sell | Tax Withholding | 3,490 | $11K | 11/15/2025 |
| Aslan Fred | ▼ Sell | Tax Withholding | 6,347 | $21K | 11/15/2025 |
| Aslan Fred | ▼ Sell | Open Market | 25,500 | $153K | 10/17/2025 |
| Raymon Heather | ▼ Sell | Tax Withholding | 1,639 | $5K | 8/15/2025 |
| Bush Jennifer | ▼ Sell | Tax Withholding | 6,409 | $18K | 8/15/2025 |
| Horan Christopher | ▼ Sell | Tax Withholding | 3,577 | $10K | 8/15/2025 |
| Neha Krishnamohan | ▼ Sell | Tax Withholding | 5,813 | $16K | 8/15/2025 |
| Aslan Fred | ▼ Sell | Open Market | 25,500 | $70K | 8/15/2025 |
| Aslan Fred | ▼ Sell | Tax Withholding | 4,472 | $12K | 8/15/2025 |
| Neha Krishnamohan | ▼ Sell | Tax Withholding | 1,341 | $3K | 5/15/2025 |
| Horan Christopher | ▼ Sell | Tax Withholding | 1,341 | $3K | 5/15/2025 |
| Bush Jennifer | ▼ Sell | Tax Withholding | 1,937 | $4K | 5/15/2025 |
| Aslan Fred | ▼ Sell | Tax Withholding | 4,472 | $10K | 5/15/2025 |
| Raymon Heather | ▼ Sell | Tax Withholding | 745 | $2K | 5/15/2025 |
| Banerjee Subhashis | ▲ Buy | Grant | 50,000 | $0 | 4/8/2025 |
| Aslan Fred | ▲ Buy | Grant | 200,000 | $0 | 3/5/2025 |
| Bush Jennifer | ▲ Buy | Grant | 86,650 | $0 | 2/26/2025 |
| Graef Thorsten | ▲ Buy | Grant | 60,000 | $0 | 2/26/2025 |
| Neha Krishnamohan | ▲ Buy | Grant | 60,000 | $0 | 2/26/2025 |
| Raymon Heather | ▲ Buy | Grant | 33,350 | $0 | 2/26/2025 |
| Horan Christopher | ▲ Buy | Grant | 60,000 | $0 | 2/26/2025 |
| Graef Thorsten | ▲ Buy | Grant | 20,000 | $0 | 9/12/2024 |
| Horan Christopher | ▲ Buy | Grant | 25,000 | $0 | 9/12/2024 |
| Neha Krishnamohan | ▲ Buy | Grant | 50,000 | $0 | 9/12/2024 |
| Raymon Heather | ▲ Buy | Grant | 10,000 | $0 | 9/12/2024 |
| Bush Jennifer | ▲ Buy | Grant | 50,000 | $0 | 9/12/2024 |
| Huh Yong-Jun | ▼ Sell | Other | 256,316 | $2.6M | 7/22/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 725,391 | — | 7/22/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 264,571 | — | 7/22/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 68,320 | — | 7/22/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 323,181 | $3.3M | 7/22/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▼ Sell | Other | 138,506 | $1.4M | 7/22/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 7,645,007 | $91.7M | 7/22/2024 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Open Market | 688,326 | $8.3M | 7/22/2024 |
| 5AM Partners VI, LLC | ▼ Sell | Other | 1,058,284 | — | 7/22/2024 |
| 5AM Partners VI, LLC | ▼ Sell | Other | 112,966 | $1.2M | 7/22/2024 |
| 5AM Partners VI, LLC | ▼ Sell | Other | 348,721 | $3.6M | 7/22/2024 |
| Huh Yong-Jun | ▼ Sell | Other | 330,095 | — | 7/22/2024 |
| Huh Yong-Jun | ▼ Sell | Other | 294,117 | $3.0M | 7/22/2024 |
| Huh Yong-Jun | ▲ Buy | Open Market | 1,666,666 | $20.0M | 7/22/2024 |
| Huh Yong-Jun | ▼ Sell | Other | 292,791 | — | 7/22/2024 |
| Huh Yong-Jun | ▼ Sell | Other | 62,181 | — | 7/22/2024 |
| Huh Yong-Jun | ▲ Buy | Open Market | 416,666 | $5.0M | 7/22/2024 |
| Aslan Fred | ▲ Buy | Grant | 228,905 | $0 | 7/22/2024 |
| 5AM Partners VI, LLC | ▲ Buy | Open Market | 833,333 | $10.0M | 7/22/2024 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | ▼ Sell | Other | 145,089 | — | 7/22/2024 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | ▼ Sell | Other | 49,019 | $500K | 7/22/2024 |
| venBio Global Strategic Fund III, L.P. | ▼ Sell | Other | 843,592 | — | 7/22/2024 |
| venBio Global Strategic Fund III, L.P. | ▼ Sell | Other | 214,692 | — | 7/22/2024 |
| venBio Global Strategic Fund III, L.P. | ▼ Sell | Other | 461,687 | — | 7/22/2024 |
| venBio Global Strategic Fund III, L.P. | ▲ Buy | Open Market | 416,666 | $5.0M | 7/22/2024 |
| GC Corp. | ▼ Sell | Other | 667,185 | — | 7/22/2024 |
| GC Corp. | ▼ Sell | Other | 330,095 | — | 7/22/2024 |
| GC Corp. | ▼ Sell | Other | 294,117 | $3.0M | 7/22/2024 |
| GC Corp. | ▲ Buy | Open Market | 1,666,666 | $20.0M | 7/22/2024 |
| GC Corp. | ▼ Sell | Other | 292,791 | — | 7/22/2024 |
| GC Corp. | ▼ Sell | Other | 62,181 | — | 7/22/2024 |
| GC Corp. | ▼ Sell | Other | 256,316 | $2.6M | 7/22/2024 |
| GC Corp. | ▲ Buy | Open Market | 416,666 | $5.0M | 7/22/2024 |
| Huh Yong-Jun | ▼ Sell | Other | 667,185 | — | 7/22/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
ARTV Announces Oral Presentation of AlloNK Data at Sjögren’s Symposium
Artiva Biotherapeutics will give an oral presentation of its AlloNK® clinical data at the 17th International Symposium on Sjögren’s Disease. The talk focuses on early results from a study in patients with this autoimmune disorder. The data could influence how investors view the company’s therapeutic pipeline. The presentation is a milestone before any formal publication or regulatory filing.
ARTV Announces Oral Presentation of AlloNK Data at Sjögren’s Symposium. Artiva Biotherapeutics will give an oral presentation of its AlloNK® clinical data at the 17th International Symposium on Sjögren’s Disease. The talk focuses on early results from a study in patients with this autoimmune disorder. The data could influence how investors view the company’s therapeutic pipeline. The presentation is a milestone before any formal publication or regulatory filing.